{"id":906906,"title":"Archive 18: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age [2021-08-27] - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T17:52:03.544000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/mrna-adolescents.html","snippet":"Archive 18: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age [2021-08-27] Publication date: August 27, 2021 Notice to reader This is an archived version. Please refer to current COVID-19 vaccine pages: NACI statements and publications…","rawSnapshotUrl":"/api/snapshots/raw/906906","browseUrl":"https://replay.healtharchive.ca/job-7/20260302175203/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/mrna-adolescents.html#ha_snapshot=906906","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}